Long-term Observations of Patients with Macular Telangiectasia Type 2 (MEMORY Study)

Long-term Observations of Patients with Macular Telangiectasia Type 2 (MEMORY Study) - MEMORY (Multicentre European Mactel2 prOgRession study)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00036004

Enrollment

1000

Registered

2025-01-24

Start date

2024-03-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Telangiectasia Type 2 (H35.071)

Interventions

Group 1: Patients with macular telangiectasia type 2 (MacTel2)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical diagnosis of MacTel 2 Written consent form

Exclusion criteria

Exclusion criteria: Refusal or lack of consent to pseudonymized documentation and electronic storage of personal data

Design outcomes

Primary

Measure	Time frame
Documentation of long-term visual acuity progressions in MacTel2 patients	—

Secondary

Measure	Time frame
Documentation of long-term retinal changes, documentation of disease progression, demographic parameters, clinical characteristics, laboratory investigations, imaging findings, as well as, if applicable in the future, complications and treatment outcomes of therapies.	—

Countries

France, Germany

Contacts

Public ContactClemens Lange

Augenzentrum am SFH

clemens.lange@augen-franziskus.de+4917661992951

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026